Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
100
NCT03046459
A First-in-Human Study of BNZ132-1-40
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 30, 2016
Completion: Jun 5, 2017
NCT03239379
A Multiple-Dose Study of Intravenous BNZ132-1-40 in Healthy Adult Subjects
Start: Oct 30, 2017
Completion: Mar 8, 2018
NCT03239392
A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL
Phase: Phase 1/2
Start: Apr 1, 2018
Completion: Jun 30, 2020